Prof. Ghassan Dbaibo, M.D., FAAP
Vice-Chair, Department of Pediatrics and Adolescent Medicine, American University of Beirut, Lebanon
After graduating from the American University of Beirut (AUB), Dr. Dbaibo trained in Pediatrics and Pediatric Infectious Diseases at Duke University in North Carolina, USA and became American Board-certified in Pediatrics and Pediatric Infectious Diseases.

After joining the faculty there for two years, Dr. Dbaibo moved back to AUB where he is now Professor of Pediatrics and Founding Head, Division of Pediatric Infectious Diseases, which he established in 2007. In 2010, he established the Primary Immunodeficiency Diseases program and the Pediatric Infectious Diseases fellowship program at AUB Medical Center. He is the Founding Director of the Center for Infectious Diseases Research based at AUB and Director of the Lebanese Inter-Hospital Pneumococcal Surveillance Program similarly based at AUB.

Dr. Dbaibo is lead investigator on many clinical protocols including several vaccine trials and infectious disease surveillance studies. In addition to his study of clinical infectious diseases in children and their prevention, his research interests include the biochemical basis of apoptosis especially in the setting of viral infection, the role of viral oncogenes in perturbing cellular signal transduction pathways, and the molecular basis of congenital immunodeficiencies. He has authored more than 100 publications in peer-reviewed journals.
Presentation - #01 John Markels, PH.D.
Welcome - #02 Nico Van Hoecke
Fadi G. Mirza, M.D., F.A.C.O.G.
Associate Professor of Obstetrics and Gynecology, Director, Obstetrics and Gynecology Residency Program, Director, Clinical Practice Improvement Program, American University of Beirut Medical Center, Adjunct Assistant Professor of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
Dr Mirza received his medical degree from the American University of Beirut before he relocated to the United States for his postgraduate training. He completed a residency in Obstetrics and Gynecology at Tufts University in Boston, Massachusetts. Following his residency, he pursued a fellowship in Maternal Fetal Medicine at Columbia University in New York, New York. He is board certified in Obstetrics and Gynecology as well as Maternal Fetal Medicine. Upon completion of his training, Dr. Mirza joined the faculty of Columbia University, where he was active in patient care, education, and research. In 2012, he joined the faculty of the American University of Beirut, yet he continues to hold an adjunct faculty appointment at Columbia University. 

Dr. Mirza is active in patient care at the American University of Beirut Medical Center. He is also an Associate Professor of Obstetrics and Gynecology at the American University of Beirut, where he teaches medical students and residents. He also assumes the position of Director of the Obstetrics and Gynecology residency training program. He also serves as the member of the Faculty of Medicine Admissions Committee and serves on the thesis committee of a number of graduate students. At an administrative level, he holds a number of senior positions; most notably, he serves as the Director of the Clinical Practice Improvement Program of the medical center and as Co-Chairperson of its Patient Safety Council. He is also the Chairperson of the hospital’s Credentialing and Privileging Committee. 

Dr. Mirza has presented numerous scientific abstracts and has published many peer-reviewed articles. He serves as a Principal Investigator for a number of research studies with funding that has exceeded USD 100,000. He currently serves as a member of the managing board of the Lebanese Society of Obstetrics and Gynecology (LSOG) and Chairman of its Scientific Committee. Additionally, he serves as the Co-Chairman of the Scientific Committee of the Federation of Arab Gynecology and Obstetrics Societies (FAGOS). He serves as an expert/investigator for the Maternal Mortality Committee of the Ministry of Public Health and is a member of the faculty of University Saint Joseph (USJ), where he contributes to the ultrasound teaching of their medical students, residents, and midwives. In 2018, he was elected to the Board of Trustees of the Makassed Philanthropic Association. 

Dr. Mirza has been an invited speaker, Course Director, and Congress Chairperson at numerous national, regional, and international conferences that have been held in Lebanon and different parts of the world, including Bahrain, China, Egypt, France, Iraq, Italy, India, Jordan, Kenya, Kingdom of Saudi Arabia, Kuwait, Morocco, Oman, Poland, Portugal, Qatar, Russia, Switzerland, Tunisia, Turkey, United Arab Emirates, and Vietnam. He is the recipient of many awards, including the Berlex Best Teaching ResidentAward, Outstanding Chief Resident Award and the prestigious Award of Research Excellence of the Society for Maternal Fetal Medicine. Given his international recognition, he has been invited to serve on a number of local, national, and international committees, including the International Federation of Gynecology and Obstetrics (FIGO)’s intrapartum fetal monitoring consensus panel.
Dr Magid Al Gunaid
Public Health Programs Director, Global Health Development | Eastern Mediterranean Public
Health Network (GHD|EMPHNET), Jordan
Dr Magid Al Gunaid, a medical doctor specialized in Health Systems Management and Public Administration.

During the period 1996-1999, Dr Al Gunaid served as the District Health Director in Ibb governorate at the Ministry of Public Health and Population (MoPHP), Yemen. After that, he was assigned as the Director of Health Insurance, and then held the Director General position of the General Planning Directorate, then the Director General of Health Policy and Technical Support Unit until mid 2004. In June 2004, he was appointed as the Deputy Minister for Primary Health Care at the Ministry of Public Health and Population, Yemen. In 2016, he Joined the Global Health Development | Eastern Mediterranean Public Health Network (GHD|EMPHNET) as the Polio and Immunization Team leader then the Public Health Programs Director since March 2020.

During the period of 2008-2011, Dr Al Gunaid was a board member with Gavi and the Global fund where he was a member of the Program and Policy Committee. In addition, he was a member of the EMR Regional Technical Advisory Group for immunisation between 2010 and 2015.
Dr.  Hossam Al Tatari
MD, FAAP, FIDSA, Department of pediatrics, Tawam Hospital, Al Ain, United Arab Emirates
Dr. Hossam Al Tatari graduated with an MD from University Medical School of Debrecen, Hungary in 1994.  After completing his Arab Board training in United Arab Emirates, he moved to USA to complete his residency and fellowship training in Michigan and become board certified by the American Board of Pediatrics in General Pediatrics and Pediatric Infectious Diseases. Dr. Al-Tatari then joined the University of Western Ontario, Canada as an adjunct professor until summer of 2009 when he moved to Tawam Hospital in UAE as the chief of pediatric infectious diseases. He became the director of the pediatric residency program between 2010 and 2017 during which he lead the program to become one of the best programs in the middle east and among the first programs to achieve the American ACGME accreditation outside of US. As of 2019, Dr. Al-Tatari has now moved to become the director of general paediatrics and pediatric infectious diseases of the Heart Medical Center in Al-Ain. UAE. He meanwhile continues to work for University of Western Ontario as a part time faculty member.

Dr. Al-Tatari has repeatedly received awards as the pediatrician and the teacher of the year in USA, Canada and UAE. Dr. Al-Tatari has more than 100 abstracts and articles in the field of pediatric infectious diseases and graduate medical education. He is also an invited keynote speaker in numerous national and international conferences. His main areas of interest are vaccines, antibiotics utilization and resistance, clinical microbiology in addition to graduate medical education and leadership skills.
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious Diseases at the Jordan University of Science and Technology, Irbid, Jordan
Dr. Wail Ahmad Hayajneh is a Professor of Pediatric Infectious Diseases at the JordanUniversity of Science and Technology (JUST) in Irbid, Jordan. He is the immediate former dean of School of Medicine at JUST which witnessed very significant jumps in international ranking over the last few years. He is also the Chairman of National Immunization Technical Advisory Group (NITAG) of Jordan and a consultant for WHO. Dr. Hayajneh had also served as Deputy CEO at King Abdullah University Hospital and part time board member of Jordanian Higher Education Accreditation Commission (HEAC).

Among other appointments, he is a part-time consultant at the King Hussein Cancer Center in Amman. He served before as the Chairman of the Jordanian Pediatric Board Committee and Chairman of Jordanian Vaccines and Sera Licensing and Re-licensing Committee. Dr. Hayajneh is a member of the Jordanian National Infection Control Committee, Jordan Experts Committee for Pandemics, and Jordan AMR different committees .Dr. Hayajneh is American Board-certified in Pediatrics, Pediatric Infectious Diseases, and Infection Control (CIC). He has also been published extensively in peer-reviewed journals, including recent papers in Lancet Infectious Diseases, Human vaccines & immunotherapeutics, BMC infectious diseases, International Journal of Infectious Diseases,Vaccine, Bone Marrow Transplant, J Obstet Gynaecol, Eur J Gynaecol Oncol, BMC Research Notes, the Journal of Medical Virology, Journal of Pediatric Gastroenterology and Nutrition and others.

Dr. Hayajneh has a special passion for Immunization, Antimicrobial Stewardship Practices, and Infection Control. He is very active along these paths at local, regional, and international levels.

Dr. Hayajneh research interest include vaccines studies, antimicrobial resistance, and infection control practices, and clinical pediatrics. He is currently the principal investigato rof several studies with special focus on defining local public health priorities forJordan.
Dr. Thomas Weinke
Head of Department, Centre for Internal Medicine, Gastroenterology and Infectious Diseases Klinikum Ernst von Bergmann
1982 - Graduation as a medical doctor (Freie Universität Berlin, Germany) 
1982-83 - General practicioner in a rural hospital in Bolivia (South America) 
1983-86 - Medical doctor in the department for infectious diseases, internal medicine (Freie Universität Berlin) 
1985 - Degree: "Diploma in Tropical Medicine and Hygiene“ (DTM&H), London 
1986 - Research stay in the London School of Hygiene and Tropical Medicine (Department of Medical Protozoology) 
1986-87 - Scientific research work in the department of medical parasitology (Robert-Koch-Institute, Berlin). Main research topics:Amoebiasis, Malaria. 
1987-1991 - Medical doctor in the department of infectious diseases, internal medicine (Freie Universität Berlin). 
1991-1997 - Medical doctor in the department of gastroenterology and infectious diseases (Klinikum Benjamin Franklin, Freie Universität Berlin). 
Since 5/97 - Head of department in the Klinikum Ernstvon Bergmann, Potsdam, department of gastroenterology and infectious diseases. 
2014-2017 - Member of the STIKO (Standing Committee on Vaccination, Germany)  

Specialization in internal medicine
Subspecialization: infectious diseases, gastroenterology, tropical medicine Main research fields: Vaccine preventable infectious diseases, gastro-intestinal infections, tropical medicine (protozoalinfections).
Professor Prakash Mohan Jeena
Clinical Head of Department – Paediatrics and Child Health Inkosi Albert Luthuli Central Hospital Durban, South Africa
Professor Prakash Mohan Jeena has an extensive experience in immunization being Head of the Paediatric ICU at King Edward VIII Hospital and the infectious diseases unit at Clairwood Hospital, Durban between 1988 and 200. Both these units were primarily created to address the scourge of the EPI related infections in children viz.  neonatal tetanus, poliomyelitis and measles and later HIV infection. Professor Prakash Mohan Jeena has elected to serve at a member of the national advisory group on immunization in South Africa.

Professor Prakash Mohan Jeena has extensive research experience in several areas of Human immunodeficiency virus research; including being the first to describe pneumocystis jirovecii and cytomegalovirus pneumonia in HIV infected African children. For nearly 20 years his work has focused on acute and chronic lung infections in HIV infected children, focusing on associated viral infections.

Professor has worked with Dr Bruce Walker and Dr Philip Goulder on cytotoxic T Cell assays amongst HIV infected children and we evaluated the role of structured treatment interruption of antiretroviral therapy among HIV infected infants. Has also been involved with work on the environmental risk factors for transmission, the pathogenic characteristic and cytokine responses among children infected with mycobacterium tuberculosis.  

These experiences and accomplishments have resulted in his being named Director of the Paediatric Critical Care Unit, Head of Paediatric Pulmonology and later Head of Paediatrics at Inkosi Albert Luthuli Central Hospital in Durban, South Africa. Professor Prakash Mohan Jeena served as Chair of the Essential Drugs Program for Paediatrics in South Africa and a member of the WHO essential medicines committee for children.

He has serve as an independent expert to International Union against tuberculosis and lung disease on the care of HIV infected children with tuberculosis and a member of the advisory committee of WHO on acute respiratory infections.

Currently, his main research area involves :
1. The effects of pollution on the respiratory outcomes of children from utero to 5 years of age - a longitudinal cohort
2. The impact of indoor air pollutants on the acquisition of Mtb in children  
3. The transmission dynamics of CMV from mother to child
4. Understanding the transmission dynamics and immunological of SARS- CoV 2 in children
Dr. Richard Malley
Senior Physician in Pediatrics, Division of Infectious Diseases, Professor of Pediatrics, Harvard Medical School, Boston, USA
Rick Malley, M.D., began his education at the Ecole Active Bilingue in Paris, France, getting his Baccalaureate in 1982.  He received his B.A. from Yale University, his M.D. from Tufts University in 1990, and pediatric infectious diseases and emergency medicine training at Boston Children’s Hospital. In 1997, a chance meeting with Dr. Porter Anderson (one of the co-inventors of the Haemophilus influenzae type b conjugate vaccine) led to his interest in the development of a species-specific pneumococcal vaccine for use in developing countries and vaccinology in general.  Under Dr. Anderson’s mentorship, he shifted his research to the development of novel vaccines against pneumococcus and other pathogens, leading to numerous scientific publications describing various aspects of pneumococcal pathogenesis and prevention, such as acquired and innate immunity, correlates of protection, and mechanisms of protection from nasopharyngeal colonization.

Dr. Malley is the Kenneth McIntosh Chair in Pediatric Infectious Diseases at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School.  Dr. Malley regularly attends on the Pediatric Infectious Diseases service at Boston Children’s Hospital, providing consultation on inpatients.  He is also the Director of the Travel and Geographic Medicine Clinic, providing advice, vaccines and medications to both adult and pediatric travelers.

Dr.Malley runs a research laboratory with past and present funding from the Meningitis Research Foundation, NIH, PATH and the Bill and Melinda Gates Foundation (BMGF), focusing on vaccine development for pneumococcus, Staphylococcusaureus, Salmonella typhi and paratyphi, and Mycobacteriumtuberculosis and more recently SARS-CoV-2.  In collaboration with PATH and the BMGF, Dr. Malley led an international effort for the development of a a pneumococcal vaccine for developing countries. In 2014, Dr. Malley and collaborators started Affinivax, a biotechnology company seed-funded by BMGFand based on a novel technology called MAPS (Multiple Antigen PresentingSystem) to develop vaccines for developing countries. Streptococcus pneumoniaeis the lead target being developed at Affinivax. A pneumococcal MAPS vaccine is currently in Phase 2 clinical testing in older adults.
Anna R. Giuliano, Ph
Director, Center for Immunization and Infection Research in Cancer (CIIRC), Moffitt Cancer Center, Tampa, Florida, USA

Anna R. Giuliano, PhD, is the founding director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center inTampa, Florida. She received her doctorate from Tufts University, Boston, Massachusetts, continuing her studies at the New England Epidemiology Institute in Boston and at the University of Arizona in Tucson as a National Cancer Prevention and Etiology Fellow. From 1993 to 1998she was the recipient of an NIH National Cancer Institute Preventive Oncology Career Development Award.

Dr Giuliano’s career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in women, and has evolved over the past 30 years to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. Her work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.

An expert in the field of cancer research with a longstanding and successful record of NationalInstitutes of Health funding since 1990, she has been actively involved in cancer epidemiology and prevention studies conducted among diverse populations in the United States and abroad. In the course of those endeavors, Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The Unequal Burden of Cancer and the2005 International Agency for Research on Cancer (IARC) report that concluded for the first time that HPV is a cause of multiple cancers in women and men. Dr.Giuliano has been honored to receive two important awards from the AmericanCancer Society (ACS). In 2013, at the ACS 100th anniversary, she was the recipient of the ACS Distinguished Achievement in Cancer Award. In 2018, she was selected for the ACS Clinical Research Professor Award for “Prevention ofInfection-Related Cancers.”  In 2019, Dr.Giuliano received the American Society of Preventive Oncology (ASPO) Fraumeni Distinguished Lifetime AchievementAward.

Dr Giuliano has authored >400 peer-reviewed publications.
John Markels, PhD
President, MSD Vaccines
John Markels is President of Vaccines at MSD. With a 100-year legacy, MSD is a global leader in Vaccines, providing abroad portfolio of pediatric, adolescent, and adult vaccines to the world. In this role, John leads an integrated team across the company dedicated to end to end research, development, supply, and access of the vaccine portfolio with the goal of helping to protect more than one billion more lives globally from vaccine preventable diseases by 2030.

John brings more than 30 years of pharmaceutical experience to this role. Immediately preceding this appointment, John was President Latin America, where he successfully led MSD’s business across the region to strong double-digit growth.

Prior to his roles in MSD’s Commercial Division, John had a long career in the manufacturing of vaccines and pharmaceuticals spanning multiple senior technical and operational roles. Most recently, he was Sr. Vice President of Emerging Markets in the MSD Manufacturing Division, with responsibility for manufacturing sites in Latin America and AsiaPacific, as well as business development, alliance management, and supply chain. His technical and operational expertise is global and spans API, formulation, sterile and vaccine manufacturing, as well as emerging markets and management of contract manufacturing globally for the company. He has led enterprise strategy programs for manufacturing, small molecule commercialization, capital acceleration and most recently, business portfolio strategy for the company. Over the course of his career, he has lived and worked in both Europe and Latin America as well as the US.

Dr. Markels received his Ph.D. in chemical engineering from the University of California, Berkeley and his B.S. in chemical engineering from the University of Delaware and serves on the Academic Advisory Board for both institutions. John also serves on the Board of Directors for Sangamo Therapeutics, Inc.
Nico Van Hoecke
MSD President for Eastern Europe, Middle East and Africa (EEMEA)
Nico Van Hoecke is MSD President for Eastern Europe Middle East and Africa (EEMEA) overseeing the human health business in 70+ countries and close to 1700 staff.

In his position as President, Nico ensures that countries in EEMEA are well equipped and able to offer patients, customers and governments with MSD’s wide range of lifesaving medicines and vaccines.

The portfolio of medicines includes an extensive range of off-patent medicines and many of MSD’s newer, innovative medicines and vaccines.

Prior to taking up his post as EEMEA President, Nico led the Finance Organization for MSD’s Emerging Markets, overseeing the financial departments of all countries in Latin America, EEMEA and Asia Pacific.

Nico started his tenure within EEMEA in 2009 as Regional Finance lead for the region. This was followed by two years as Business & Commercial Operations lead for the same region. These two positions together with his experience as Emerging Markets Finance lead have served to help him understand the intricacies of working in a challenging and very rewarding region.

Nico is a Belgian National with a Masters in Corporate Income Taxes and Commercial Sciences, Specialty in Accountancy; and a Bachelor’s Degree in Commercial Sciences all from EHSAL in Brussels.

Prior to joining MSD in 1998, Nico was an External Auditor with Deloitte Touche.
Ali AlBarrak
Consultant Internal Medicine and Infectious Diseases – Prince Sultan Military Medical City Kingdom of Saudi Arabia
Dr Al-Barrak is currently senior Consultant Internal Medicine and Infectious Diseases at Prince Sultan Military Medical City, Saudi Arabia.

Dr Al-Barrak obtained his Diploma in Internal Medicine (American Board of Internal Medicine) in 1997 and in 1998 was nominated a Fellow of The Royal College of Physicians of Canada in Internal Medicine. In 1999, Dr Al-Barrak was awarded a Special Competence in Infectious Diseases from The Royal College of Physicians of Canada and a Diploma in Tropical Medicine and Hygiene from Georgas Memorial Institute of Tropical and Preventive Medicine and Institute de Medicina Tropical “Alexander Von Humboldt”.

Was appointed as General Director for the Saudi Center for Disease control at Ministery of health from 2014-2017. He was also a member of the GCC Advisory Board for Infection Control from 2009–2015. Has many national medallist and distinction .

Dr Al-Barrak has published over 40 articles in various peer-reviewed medical journals. He is currently the Associate Editor of the Saudi Medical Journal and has published eight editorial articles as Editor-in-Chief in Saudi Medical Journal. Additionally, Dr Al-Barrak is on the editorial board of the Journal of Epidemiology and Global Health and the Journal of Public Health. He is currently an associate member of Canadian Infectious Disease Society and is an active member of several national associations including; the Saudi Thoracic Society and the Infectious Diseases Scientific Committee at the Ministry of Health.
Prof. Paolo Bonanni
Full Professor of Hygiene in the Faculty of Medicine, University of Florence, Italy
Since 2000, Paolo Bonanni is Full Professor of Hygiene in the Faculty of Medicine, University of Florence, Italy. From 2011 to 2019 he has been the Director of the Specialization School for MDs in Hygiene and Preventive Medicine at the University of Florence.

His scientific activity hascovered the epidemiology and prevention of infectious diseases, particularly viral hepatitis, diphtheria, tetanus, pertussis, influenza, measles, rubella, varicella, and, most recently, bacterial invasive diseases and HPV, including clinical trials and economic evaluation of vaccination strategies.

He has been a member of the National Vaccination Commission of the Italian Ministry of Health, and he acts as an expert consultant for the European Centre for Disease Prevention andControl (ECDC) based in Stockholm.

He has been a member of the European Technical Group of Experts on Immunization (ETAGE) at WHO Euro, Copenhagen, from 2012 to 2017. He still collaborates with WHO-EURO and ETAGE on specific projects (i.e. he is a member of the Committee for the Verification of Hepatitis B control at present).

He is standing adviser of the Viral Hepatitis Prevention Board (VHPB), an international independent committee of experts in viral hepatitis prevention, and of the International Human Papilloma Virus Prevention Board an international independent committee of experts on HPV prevention. He received several grants from the Italian Ministry of University and the Italian Ministry of Health (Centre for Disease Control or CCM) on projects regarding vaccine-preventable infections. Paolo Bonanni was research unit leader in 4 EU-funded projects on vaccination, and presently coordinatingthe University of Florence Unit participating as one of the main partners in the EU Innovative Medicine Initiative on brand-specific influenza vaccination effectiveness named DRIVE (Development of Robust Influenza Vaccine Effectiveness).

Paolo Bonanni is the author orco-author of 300 scientific papers published in international and national journals.
Dr. Karim Elmasry
Lead for gynae-oncology services at Mediclinic Middle East, UAE
Dr Karim Elmasry is a British, Royal Collegeof Obstetrics & Gynaecology dual accredited Obstetrician & Gynecologistand Subspecialist Gynecological Oncologist.

Having qualified from the University of Nottingham Medical School, he underwent training in Obstetrics and Gynecology in major teaching hospitals in Nottingham and London. He then undertook subspecialty training in gynecological oncology at Guy’s & St Thomas’ Hospital, UK. 

Dr Elmasry has been in the UAE for the last 10 years working initially in the government sector and now in the private sector developing gynae-oncology services. Where he is the lead for gynae-oncology services at Mediclinic Middle East. In 2010 he was invited by the Department of Health of Abu Dhabi to be a founder member of the cervical screening task force. He has received many national and international awards for his work helping women with gynecological cancers including the 2015 ‘Al Wessam Champion’ (SEHA Best Physician category in the ‘Physician & Technical Award’ Category) and he is often asked to speak at international conferences and on TV and radio as an expert on this topic.  

Dr Elmasry is also an Adjunct Assistant Professor at John’s Hopkins Hospital in Baltimore and Associate Professor at MBRU in Dubai and has numerous publications in peer reviewed journals.
September 21-24, 2020
EEMEA VACCINNOVATION 
Virtual SUMMIT 2020
Vaccine Experts coming together
Now more than ever
0
Days
0
Hours
0
Minutes
0
Seconds
REGISTER NOW!
WHAT IS THE EEMEA VACCINNOVATION 
VIRTUAL SUMMIT 2020?
Now more
than ever
The COVID-19 pandemic has brought the importance of the value of vaccines to the fore. Now, more than ever in recent human history, it is important to bring the best of our shared knowledge, resources and experiences in immunization to save lives.
An Innovative
virtual event
The EEMEA Vaccinnovation Virtual Summit 2020 is an innovative, 3D fully immersive experience allowing you to engage with renowned international speakers and peers from 20 countries. Learn about the latest advancements in vaccination and advance our collective knowledge on how to build successful immunization programs, especially during this challenging period.
Key
topics
  • Latest advancements in vaccination
  • Vaccine confidence
  • Vaccine development and manufacturing
  • HPV & Pneumococcal vaccination
  • Pediatric vaccination
Livestreaming and
Interactive sessions
  • 4 days of scientific exchange & engagement
  • 13 live sessions
  • 12 international speakers
  • Peers from 20 countries
  • Listen to the live sessions in English or simultaneously translated in French or Russian
A UNIQUE 3D VIRTUAL EXPERIENCE
Get to know more about Vaccination in our virtual exhibit hall
13 live sessions, 12 international speakers
Network with your peers from 20 countries across Eastern Europe, the Middle East and Africa
Vaccination Experts coming together, Now more than ever
REGISTER NOW!
If you are MSD staff please click here to register
REGISTER NOW!
If you are MSD staff please click here to register
Schedule
Listen to the live sessions in English or simultaneously translated in French or Russian
Regaining Trust in Vaccination
  • Discuss the landscape of immunization in EEMEA,
    including the role of immunization and challenges faced
  • Understand the impact of COVID-19 on routine
    immunization, and discuss the innovations on how
    to maintain routine immunization services during crisis
  • Debate the vaccine confidence in the age of COVID-19
    pandemic, including the role of social media
  • Deepen understanding on the complexity of
    manufacturing vaccines
21 September, 4.00 - 6.00 PM CET Regaining Trust in Vaccination
Chair: Dr. Wail Ahmad Hayajneh (Jordan)
SPEAKERS
Opening and welcoming
Tidiane Ndao - Director, Medical Affairs.
Europe Vaccines Medical Affairs
Chair’s opening remarks
Dr. Wail Ahmad Hayajneh - Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology, Jordan
Keynotes by MSD
Nico Van Hoecke - MSD President for Eastern Europe, Middle East and Africa
John Markels, PH.D.- President - Global Vaccines MSD
Routine Immunization in Eastern Mediterranian
Region: achievements and perspectives
Dr. Magid Al-Gunaid - Public Health Programs Director, Global Health Development | Eastern Mediterranean Public Health Network (GHD|EMPHNET), Jordan
Vaccine confidence and Social Media
Dr. Hossam Al Tatari - Director of General Pediatrics and Pediatric Infectious Diseases Services, The Heart Medical Center, UAE
Complexity of Vaccines Manufacturing and MSD approach to meeting global demand
MSD - MMD
Q&A and Panel Discussion: COVID-19 and risk of VPD outbreaks; routine immunization in the new normal, supply, HCPs and social media
All Speakers
Closing remarks and agenda of next 3 days
Dr. Wail Ahmad Hayajneh - Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology, Jordan
Monday, 21st September from 4.00 to 6.00 PM CET
Regaining Trust in Vaccination
CHAIR: Dr. Wail Ahmad Hayajneh, Jordan
Opening and welcoming
Hesham Fouad
Dir, Regional Marketing, Vaccine Intl
Commercial Operations (MSD)
Chair’s opening remarks
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology,
Jordan
MSD keynotes
Nico Van Hoecke
President - Eastern Europe, Middle East & Africa Region, MSD
Story of our Vaccines
John Markels (MSD)
President - Global Vaccines, MSD
Routine Immunization in Eastern Mediterranian Region:
Achievements and perspectives
Dr. Magid Al Gunaid
Public Health Programs Director, Global
Health Development | Eastern Mediterranean
Public Health Network (GHD|EMPHNET),
Jordan
Does COVID-19 uncover the unknown fragility of the
immunizations systems? The Case of KSA
Dr. Ali Al Barrak
Consultant Internal Medicine and Infectious
Diseases-Prince Sultan Military Medical City,
Kingdom of Saudi Arabia
Vaccine confidence and Social Media
Dr. Hossam Al Tatari
Director of General Pediatrics and Pediatric
Infectious Diseases Services, The Heart
Medical Center, UAE
Q&A and panel discussion: COVID-19 and risk of VPD
outbreaks; routine immunization in the new normal,
supply, HCPs and social media
Chair & All
Closing remarks
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology, Jordan
Pneumococcal Vaccination
  • Understand rationale, current recommendations and opportunities for adult Pneumococcal vaccination
  • Be exposed to latest scientific data on effectiveness and impact of Pneumococcal vaccines in adults worldwide
  • Learn about the impact of pediatric immunization program on serotypes causing adult disease
  • Discuss unmet needs in adult and pediatric vaccination, including new pneumococcal vaccines development
22 September, 4:00 – 6:00 PM CET
Pneumococcal diseases prevention: Can We do more and better?
Chair: Prof. Ghassan Dbaibo (Lebanon)
SPEAKERS
Pneumococcal Disease Burden in the Region:
The Known and Unknown
Prof. Ghassan Dbaibo, M.D., FAAP - Vice-Chair, Department of Pediatrics and Adolescent Medicine, American University of Beirut, Lebanon
Pediatric Pneumococcal Vaccination:
the present and the future
Dr. Richard Malley,  M.D. - Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital. Professor of Pediatrics, Harvard Medical School, USA(USA)
Adult Pneumococcal Vaccination:
Rationale, Recommendations & Best practices
Prof. Dr. Thomas Weinke - Head of Department, Centre for Internal Medicine, Gastroenterology and Infectious Diseases, Klinikum Ernst von Bergmann, Germany
Q&A and Panel Discussion: perspectives, mass gatherings, adult immunization and COVID-19…
Chair & All Speakers
Tuesday, 22nd September from 4.00 to 6.00 PM CET
Pneumococcal diseases prevention: Can we do more and better?
CHAIR: Prof. Ghassan Dbaibo, Lebanon
Chair’s Opening Remarks
Pneumococcal Disease Burden in the Region:
The Known and Unknown
Prof. Ghassan Dbaibo
Vice-Chair, Department of Pediatrics and Adolescent Medicine, American University of Beirut, Lebanon
Pediatric Pneumococcal Vaccination:
The present and the future
Dr. Richard Malley
Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital. Professor of Pediatrics, Harvard Medical School, USA
Adult Pneumococcal Vaccination: Rationale,
Recommendations & Best practices
Prof. Dr. Thomas Weinke
Head of Department, Centre for Internal Medicine, Gastroenterology and Infectious Diseases, Klinikum Ernst von Bergmann, Germany
Q&A and panel discussion: Perspectives,
mass gatherings, adult immunization and COVID-19…
Chair & All
Closing remarks
Prof. Ghassan Dbaibo
Vice-Chair, Department of Pediatrics and Adolescent Medicine, American University of Beirut, Lebanon
HPV
  • What does a successful HPV vaccination program look like?
  • Discuss what it takes to reach HPV elimination goals in EEMEA
  • Get the latest real word effectiveness and impact data for Gardasil and Gardasil 9 in in adolescent males and females, adult women.
  • Understand benefits of HPV vaccination in males and adult women
  • Understand the 14 years long term follow-up data of Gardasil
  • Understand the 8 years long term follow-up data of Gardasil 9
23 September, 4:00 – 6:00 PM CET
HPV Vaccination in EEMEA
SPEAKERS
Effectiveness and Impact of HPV vaccines
Dr. Fadi G. Mirza, M.D., F.A.C.O.G. - Associate Professor of Obstetrics and Gynecology Director, American University of Beirut Medical Center, Lebanon
Extending benefits of HPV vaccines:
rationale for GNV
Anna R. Giuliano , PhD- Professor and Director
Center for Immunization and Infection Research in Cancer (CIIRC),H. Lee Moffitt Cancer Center & Research Institute, USA
Q&A and Panel Discussion: HPV vaccines and COVID-19, Pros/cons GNV in EEMEA, post infection vaccination, HCPs recommendation, role of social media, alternate dosing, elimination
Chair + Speakers
Wednesday, 23rd September from 4.00 to 6.00 PM CET
HPV Vaccination in EEMEA
CHAIR: Dr. Karim Elmasry, UAE
Chair’s Opening Remarks
Dr. Karim Elmasry
Lead for gynae-oncology services at Mediclinic Middle East, UAE
Effectiveness and Impact of HPV vaccines
Dr. Fadi G. Mirza
Associate Professor of Obstetrics and Gynecology Director, American University of Beirut Medical Center, Lebanon
Extending benefits of HPV vaccines: Rationale for GNV
Prof. Anna R. Giuliano
Professor and Director, Center for
Immunization and Infection Research in
Cancer (CIIRC), H. Lee Moffitt Cancer
Center & Research Institute, USA
Implementing HPV Vaccination in an NIP: the case of UAE
Dr. Karim Elmasry
Lead for gynae-oncology services at Mediclinic Middle East, UAE
Q&A and panel discussion: HPV vaccines and COVID-19,
Pros/cons GNV in EEMEA, post infection vaccination,
HCPs recommendation, role of social media,
alternate dosing, elimination
Chair & All
Closing remarks
Dr. Karim Elmasry
Lead for gynae-oncology services at Mediclinic Middle East, UAE
Pediatric Vaccines
  • Discuss the achievements, challenges and perspectives in Pediatric vaccines.
  • Grow awareness on the root causes of outbreaks-prone vaccine preventable diseases (VPDs) despite high coverage rates
  • Understand the impact of Vaccination on the epidemiology of VPD, including public health and societal benefits
  • Share best practices on decision making processes for new vaccines introduction into National Immunization Programs
24 September, 4:00 – 6:10 PM CET
Maximizing the impact of routine immunization in EEMEA.
Chair: Prof. Prakash Mohan Jeena (South Africa)
SPEAKERS
Why do we still see VPD outbreaks in EEMEA?
Root Causes and Possible Solutions
Prof.Prakash Mohan Jeena - Clinical Head of Department-Paediatrics and Child Health, Inkosi Albert Luthuli Central Hospital, South Africa
Evidence-based approach for Vaccines introduction into NIP – The case for Jordan
Dr. Wail Ahmad Hayajneh - Professor of Pediatric Infectious
Diseases, Jordan University of Science and Technology, Jordan
Q&A and Panel Discussion
Chair & All Speakers
Closing of the summit
Dr. Wail Ahmad Hayajneh - Professor of Pediatric Infectious
Diseases, Jordan University of Science and Technology, Jordan
Thursday, 24th September from 4.00 to 6.10 PM CET
Maximizing the impact of routine immunization in EEMEA
CHAIR: Prof. Prakash Mohan Jeena, South Africa
Chair’s Opening Remarks
Why do we still see VPD outbreaks in EEMEA?
Root Causes and Possible Solutions
Prof. Prakash Mohan Jeena
Clinical Head of Department-Paediatrics
and Child Health, Inkosi Albert Luthuli
Central Hospital, South Africa
Evidence-based approach for Vaccines introduction into
NIP - The case for Jordan
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology, Jordan
Varicella Vaccination from public health perspectives;
Experience from Italy
Prof. Paolo Bonanni
Full Professor of Hygiene in the Faculty of Medicine, University of Florence, Italy
Q&A and panel discussion
Chair & All
Closing of the Virtual Summit
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious Diseases, Jordan University of Science and Technology, Jordan
Keynote Session with Benjam Le Panse
10:00 AM
  • Brainsonic Academy - UX Session
  • Brainsonic Academy - UX Session
  • Brainsonic Academy - UX Session
OUR SPEAKERS
Dr Magid Al Gunaid
Public Health Programs Director, Global Health Development | Eastern Mediterranean Public
Health Network (GHD|EMPHNET), Jordan
Dr Magid Al Gunaid, a medical doctor specialized in Health Systems Management and Public Administration.

During the period 1996-1999, Dr Al Gunaid served as the District Health Director in Ibb governorate ...
See more
Dr. Wail Ahmad Hayajneh
Professor of Pediatric Infectious
Diseases, Jordan University
of Science and Technology, Jordan
Dr. Wail Ahmad Hayajneh is a Professor of Pediatric Infectious Diseases at the Jordan University of Science and Technology (JUST) in Irbid, Jordan. He is the immediate former dean of School of Medicine at JUST which witnessed very significant jumps in international ranking over the last few years. He is also the Chairman of National Immunization ...
See more
Dr.  Hossam Al Tatari
Director of General Pediatrics and Pediatric Infectious Diseases Services, The Heart Medical Center, UAE
Dr. Hossam Al Tatari graduated with an MD from University Medical School of Debrecen, Hungary in 1994.  After completing his Arab Board training in United Arab Emirates, he moved to USA to complete his residency and fellowship training in Michigan and become board certified by the American Board of Pediatrics in General Pediatrics and Pediatric Infectious Diseases. Dr. Al-Tatari then joined the ...
See more
Prof. Ghassan Dbaibo, M.D., FAAP
Vice-Chair, Department of Pediatrics and Adolescent Medicine, American University of Beirut, Lebanon
After graduating from the American University of Beirut (AUB), Dr. Dbaibo trained in Pediatrics and Pediatric Infectious Diseases at Duke University in North Carolina, USA and became American Board-certified in Pediatrics and Pediatric Infectious Diseases. After joining the faculty there for two years, Dr. Dbaibo moved back to AUB where he is now Professor of Pediatrics and Founding Head, Division of Pediatric Infectious Diseases, which he ...
See more
Dr. Fadi G. Mirza, M.D., F.A.C.O.G.
Associate Professor of Obstetrics and Gynecology Director, American University of Beirut Medical Center, Lebanon
Dr Mirza received his medical degree from the American University of Beirut before he relocated to the United States for his postgraduate training. He completed a residency in Obstetrics and Gynecology at Tufts University in Boston, Massachusetts. Following his residency, he pursued a fellowship in Maternal Fetal Medicine at...
See more
John Markels, PH.D.
President - Global Vaccines MSD
John Markels is President of Vaccines at MSD. With a 100-year legacy, MSD is a global leader in Vaccines, providing abroad portfolio of pediatric, adolescent, and adult vaccines to the world. In this role, John leads an integrated team across the company dedicated to end research, development, supply, and access of the vaccine portfolio with the goal of helping to protect more than one billion more lives globally ...
See more
Nico Van Hoecke
MSD President for Eastern Europe, Middle East and Africa (EEMEA)
Nico Van Hoecke is MSD President for Eastern Europe Middle East and Africa (EEMEA) overseeing the human health business in 70+ countries and close to 1700 staff.In his position as President, Nico ensures that countries in EEMEA are well equipped and able to offer patients, customers and governments with MSD’s wide range of lifesaving...
See more
Ali AlBarrak
Consultant Internal Medicine and Infectious Diseases – Prince Sultan Military Medical City Kingdom of Saudi Arabia
Dr Al-Barrak is currently senior Consultant Internal Medicine and Infectious Diseases at Prince Sultan Military Medical City, Saudi Arabia.Dr Al-Barrak obtained his Diploma in Internal Medicine ...
See more
Prof. Paolo Bonanni
Full Professor of Hygiene in the Faculty of Medicine,University of Florence, Italy
Since 2000, Paolo Bonanni is Full Professor of Hygiene in the Faculty of Medicine, University of Florence, Italy. From 2011 to 2019 he has been the Director of the Specialization School for MDs in Hygiene and Preventive Medicine at the University of Florence. His scientific activity has covered the ...
See more
Dr. Karim Elmasry
Lead for gynae-oncology services at Mediclinic Middle East, UAE
Dr Karim Elmasry is a British, Royal College of Obstetrics & Gynaecology dual accredited Obstetrician & Gynecologist and Subspecialist Gynecological Oncologist. Having qualified from the University of Nottingham Medical School, he underwent training in Obstetrics and Gynecology in ...
See more
THE MSD LEADERSHIP INVITES 
YOU TO VACCINNOVATION
REGISTER NOW!
If you are MSD staff please click here to register